相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Safety and efficacy of restarting immune checkpoint inhibitors after clinically significant immune-related adverse events in metastatic renal cell carcinoma
Sarah Abou Alaiwi et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in Patients With Cancer
Charles Dolladille et al.
JAMA ONCOLOGY (2020)
Safety of immune checkpoint inhibitor rechallenge after discontinuation for grade ≥2 immune-related adverse events in patients with cancer
Marion Allouchery et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Neurological side effects of checkpoint inhibitors
S. Knauss et al.
NERVENARZT (2019)
Evaluation of Readministration of Immune Checkpoint Inhibitors After Immune-Related Adverse Events in Patients With Cancer
Audrey Simonaggio et al.
JAMA ONCOLOGY (2019)
Antibody-Mediated Encephalitis
Josep Dalmau et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Miller Fisher Syndrome Associated With Immunotherapy for Metastatic Melanoma
Onathan J. D. Baird-Gunning et al.
NEUROHOSPITALIST (2018)
Neurotoxicity from immune-checkpoint inhibition in the treatment of melanoma: a single centre experience and review of the literature
L. Spain et al.
ANNALS OF ONCOLOGY (2017)
Two cases of clinical myasthenia gravis associated with pembrolizumab use in responding melanoma patients
Bella H. V. Nguyen et al.
MELANOMA RESEARCH (2017)
The pathology of adverse events with immune checkpoint inhibitors
V. H. Koelzer et al.
PATHOLOGE (2017)
Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
J. B. A. G. Haanen et al.
ANNALS OF ONCOLOGY (2017)
Pembrolizumab-Induced Demyelinating Polyradiculoneuropathy
Marie-Florence de Maleissye et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Ipilimumab-Induced Encephalopathy with a Reversible Splenial Lesion
Robert M. Conry et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Severe relapse in a multiple sclerosis patient associated with ipilimumab treatment of melanoma
Edward J. Gettings et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Atypical neurological complications of ipilimumab therapy in patients with metastatic melanoma
Bing Liao et al.
NEURO-ONCOLOGY (2014)
The Price of Tumor Control: An Analysis of Rare Side Effects of Anti-CTLA-4 Therapy in Metastatic Melanoma from the Ipilimumab Network
Caroline J. Voskens et al.
PLOS ONE (2013)
分享论文
